Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload
- 1 October 1998
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 275 (4), H1200-H1208
- https://doi.org/10.1152/ajpheart.1998.275.4.h1200
Abstract
We have recently identified a novel amino-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) in the circulation of humans, the concentration of which increases progressively as the left ventricle fails. To clarify the origins of NT-proBNP in experimental animals, we have developed an RIA for NT-proBNP based on residues 52–71 of ovine proBNP-(1—103) and used it to study cardiac processing, secretion, and metabolism of BNP in sheep with cardiac overload induced by coronary artery ligation (CAL) or rapid left ventricular pacing (rLVP). The concentration of NT-proBNP in left atrial plasma extracts drawn from normal control sheep was threefold that of mature BNP. Size-exclusion and reverse-phase HPLC analyses of plasma extracts coupled to RIA revealed a single peak of immunoreactive (ir) NT-proBNP [∼8,000 relative molecular weight ( Mr)], quite distinct from a single peak of ir-mature BNP (∼3,000 Mr). In contrast, ovine cardiac tissue contained only a single immunoreactive peak of high-molecular-weight BNP (∼11,000 Mr), consistent in size with proBNP-(1—103). Sampling from the cardiac coronary sinus in normal control sheep ( n = 5) and sheep with CAL ( n = 5) revealed that the molar ratio of NT-proBNP to mature BNP was similar. There was a significant gradient of both mature and NT-proBNP across the heart in normal sheep, whereas after CAL the gradient was significant for mature BNP only. In both forms of cardiac overload (CAL and rLVP), left atrial plasma levels of NT-proBNP were significantly increased above normal levels, in contrast with mature BNP levels, which were raised only in the rLVP group of animals. Blockade of natriuretic peptide metabolism in sheep with heart failure (induced by rLVP) raised mature BNP levels threefold but did not affect levels of NT-proBNP. In conclusion, these studies show that NT-proBNP is formed from proBNP stores during secretion and, compared with mature BNP, accumulates in plasma because metabolism of NT-proBNP appears to differ from that of mature BNP. Although its function, if any, remains unclear, plasma NT-proBNP may prove to be a sensitive marker of cardiac overload and/or decompensation.Keywords
This publication has 30 references indexed in Scilit:
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature.Heart, 1996
- The Amino-Terminal Portion of Pro-Brain Natriuretic Peptide (Pro-BNP) Circulates in Human PlasmaBiochemical and Biophysical Research Communications, 1995
- Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.Heart, 1995
- Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.Hypertension, 1992
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasmaBiochemical and Biophysical Research Communications, 1987
- Identification of a biologically active circulating form of rat atrial natriuretic factorBiochemical and Biophysical Research Communications, 1985
- Molecular forms of atrial natriuretic polypeptides in mammalian tissues and plasmaBiochemical and Biophysical Research Communications, 1985